TL;DR: SFA Therapeutics is a Y Combinator Summer 2021 startup Regulating the immune system to block cancer & autoimmune diseases, currently active with a team of 4.
Regulating the immune system to block cancer & autoimmune diseases
Last verified:
SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system; with a focus on autoimmune diseases and cancers that originate from chronic inflammation. There are over 300 million patients who suffer from autoimmune diseases. Our treatment is designed to block the root cause of many of these chronic inflammatory diseases, with safe oral drugs. We have strong clinical data from a phase 1b clinical trial in psoriasis, and human data in pancreatic cancer, uveitis and NASH. we have a total of 9 drugs in our pipeline and 15 patents.
Built by LemStudio
Yes. SFA Therapeutics was funded by Y Combinator in the Summer 2021 batch. Regulating the immune system to block cancer & autoimmune diseases
SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system; with a focus on autoimmune diseases and cancers that originate from chronic inflammation. There are over 300 million patients who suffer from autoimmune diseases. Our treatment is designed to block the root cause of many…
SFA Therapeutics was part of Y Combinator's Summer 2021 batch.
SFA Therapeutics has a team of 4 people according to Y Combinator's directory.
SFA Therapeutics is currently listed as Active with a team of 4 in Y Combinator's directory.
Loading interactive view…